BACMIN (Marnel Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the BACMIN drug offered from Marnel Pharmaceuticals, Inc.. This Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Marnel Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: VITAMIN A ACETATE, .ALPHA.-TOCOPHEROL ACETATE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, BIOTIN, CALCIUM PANTOTHENATE, FOLIC ACID, CYANOCOBALAMIN, FLAVONE
SUBSTANCE NAME: VITAMIN A ACETATE; .ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CALCIUM PANTOTHENATE; FOLIC ACID; CYANOCOBALAMIN; FLAVONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin A [Chemical/Ingredient],Vitamin A [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [Chemical/Ingredient],Vitamin B12 [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET, COATED
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2000-04-01
END MARKETING DATE: 0000-00-00


BACMIN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBACMIN from Marnel Pharmaceuticals, Inc.
LABELER NAME: Marnel Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 2000; 30; 500; 20; 20; 100; 25; 150; 25; 1; 50; 50; 27; .1; 50; 5; 3; 50; 22.5([iU]/1; [iU]/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1)
START MARKETING DATE: 2000-04-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0682-3001_ed775d39-46ec-4014-a727-232ab02b6f10
PRODUCT NDC: 0682-3001
APPLICATION NUMBER:

Other VITAMIN A ACETATE; .ALPHA.-TOCOPHEROL ACETATE; ASCORBIC ACID; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; BIOTIN; CALCIUM PANTOTHENATE; FOLIC ACID; CYANOCOBALAMIN; FLAVONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Marnel Pharmaceuticals, Inc.BACMIN